Literature DB >> 2132688

Theileria parva: the nature of the immune response and its significance for immunoprophylaxis.

D J McKeever1, W I Morrison.   

Abstract

Theileria parva is a tick-borne haemoprotozoan parasite of cattle and buffalo which is responsible for considerable economic losses to cattle farming in Eastern, Central and Southern Africa. Infection with the parasite results in an acute lymphoproliferative disorder with high mortality, but animals which survive infection are solidly immune to homologous challenge. Such immunity can be reproduced by infecting cattle with the parasite and treating them with tetracyclines or theilericidal drugs, but the widespread use of this technique as a method of control is hindered by its dependence on live parasites which require cryopreservation for maintenance and can give rise to carrier states. In addition, cross-protection between different strains of the parasite is not absolute. These problems have prompted a search for methods of immunisation based on the use of inactivated parasites or their derivatives. Such efforts have met with consistent failure, however, and in recent years scientists have adopted the more rational approach of defining the immune responses of cattle to the parasite with a view to identifying the parasite components which provoke them. These studies have revealed that protection is likely to be mediated by parasite-specific cytotoxic T cells which are restricted by class I major histocompatibility complex (MHC) products. The significance of this observation to the development of an effective subunit vaccine is discussed in the light of current knowledge of the inductive requirements of cytotoxic T cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2132688     DOI: 10.20506/rst.9.2.504

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  6 in total

1.  Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle.

Authors:  I Gentschev; I Glaser; W Goebel; D J McKeever; A Musoke; V T Heussler
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Tick salivary gland extract and interleukin-2 stimulation enhance susceptibility of lymphocytes to infection by Theileria parva sporozoites.

Authors:  M K Shaw; L G Tilney; D J McKeever
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

3.  Parasite strain specificity of precursor cytotoxic T cells in individual animals correlates with cross-protection in cattle challenged with Theileria parva.

Authors:  E L Taracha; B M Goddeeris; S P Morzaria; W I Morrison
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

4.  The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence.

Authors:  Martin Norling; Richard P Bishop; Roger Pelle; Weihong Qi; Sonal Henson; Elliott F Drábek; Kyle Tretina; David Odongo; Stephen Mwaura; Thomas Njoroge; Erik Bongcam-Rudloff; Claudia A Daubenberger; Joana C Silva
Journal:  BMC Genomics       Date:  2015-09-24       Impact factor: 3.969

5.  Antigenic Diversity in Theileria parva Populations From Sympatric Cattle and African Buffalo Analyzed Using Long Read Sequencing.

Authors:  Fiona K Allan; Siddharth Jayaraman; Edith Paxton; Emmanuel Sindoya; Tito Kibona; Robert Fyumagwa; Furaha Mramba; Stephen J Torr; Johanneke D Hemmink; Philip Toye; Tiziana Lembo; Ian Handel; Harriet K Auty; W Ivan Morrison; Liam J Morrison
Journal:  Front Genet       Date:  2021-07-15       Impact factor: 4.599

6.  Combining Landscape Genomics and Ecological Modelling to Investigate Local Adaptation of Indigenous Ugandan Cattle to East Coast Fever.

Authors:  Elia Vajana; Mario Barbato; Licia Colli; Marco Milanesi; Estelle Rochat; Enrico Fabrizi; Christopher Mukasa; Marcello Del Corvo; Charles Masembe; Vincent B Muwanika; Fredrick Kabi; Tad Stewart Sonstegard; Heather Jay Huson; Riccardo Negrini; Stéphane Joost; Paolo Ajmone-Marsan
Journal:  Front Genet       Date:  2018-10-03       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.